Role of surgery in the treatment of microprolactinomas

Neurosurgery Clinics of North America

Volumn 14, Issue 1, 2003, Pages 89-92

  Couldwell, William T ^a   Rovit, Richard L ^b   Weiss, Martin H ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ST VINCENT S HOSPITAL   (United States)

^c LAC USC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; HYPOPHYSECTOMY; PRIORITY JOURNAL; PROLACTINOMA; RADIOSURGERY; REVIEW; STEREOTAXIC SURGERY; TREATMENT INDICATION; TUMOR VOLUME;

HUMANS; NEUROSURGICAL PROCEDURES; PITUITARY NEOPLASMS; PROLACTINOMA; STEREOTAXIC TECHNIQUES;

EID: 0037266062     PISSN: 10423680     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1042-3680(02)00090-6     Document Type: Review

References (22)

1. Terada T, Kovacs K, Stefaneanu L, Horvath E. Incidence, pathology, and recurrence of pituitary adenomas: study of 647 unselected surgical cases. Endocr Pathol 1995;6:301-10.
2. Ciric I, Rosenblatt S, Kerr W Jr, Lamarca F, Pierce D, Baumgartner C. Perspective in pituitary adenomas: an end of the century review of tumorigenesis, diagnosis and treatment. Clin Neurosurg 2000;47:99-111.
3. Colao A, Annunziato L, Lombardi G. Treatment of prolactinomas. Ann Med 1998;30:452-9.
4. Gokalp HZ, Deda H, Attar A, Ugur HC, Arasil E, Egemen N. The neurosurgical management of prolactinomas. J Neurosurg Sci 2000;44:128-32.
5. Liuzi A, Oppizzi G. Microprolactinomas: why requiem for surgery? J Endocrinol Invest 1996;19:196-8.
6. Molitch ME. Medical treatment of prolactinoma. Endocrinol Metab Clin N Am 1999;28:142-69.
7. Ozgen T, Oruckaptan HH, Ozcan OE, Acikgoz B. Prolactin secreting pituitary adenomas: analysis of 429 surgically treated patients, effect of adjuvant treatment modalities and review of the literature. Acta Neurochir (Wien) 1999;141:1287-94.
8. Rees DA, Davies JS, Scanlon MF. Microprolactinoma: medical or surgical treatment as first line approach? The case for medical therapy. J Endocrinol Invest 2000;23:122-4.
9. Zacur HA. Indications for surgery in the treatment of hyperprolactinemia. J Reprod Med 1999;44 (Suppl 12):1127-31.
10. Faglia G. Prolactinomas and hyperprolactinemic syndrome. In: DeGroot LJ, Jameson JL, editors. Endocrinology. 4th edition. Philadelphia: WB Saunders; 2001. p. 329-42.
11. Di Sarno A, Landi ML, Marzullo P, et al. The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas. Clin Endocrinol (Oxf) 2000;53:53-60.
12. DelGrange E, Maiter D, Donckier J. Effects of the dopamine agonist cabergoline in patients with prolactinoma intolerant or resistant to bromocriptine. Eur J Endocrinol 1996;134:454-6.
13. Molitch ME. Management of prolactinomas during pregnancy. J Reprod Med 1999;44(Suppl 12):1121-6.
14. Liu J, Das K, Weiss MH, Laws ER, Couldwell WT. The history and evolution of transsphenoidal surgery. J Neurosurg 2001;95:1083-96.
15. Tyrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB. Transsphenoidal microsurgical therapy of prolactinomas: initial outcomes and long-term results. Neurosurgery 1999;44:254-61.
16. Turner HE, Adams CB, Wass JA. Transsphenoidal surgery for microprolactinoma: an acceptable alternative to dopamine agonists? Eur J Endocrinol 1999;140:43-7.
17. Kim SH, Huh R, Chang JW, et al. Gamma knife radiosurgery for functioning pituitary adenomas. Stereotact Funct Neurosurg 1999;72(Suppl 1):101-10.
18. Kim MS, Lee SI, Sim JH. Gamma knife radiosurgery for functioning pituitary microadenoma. Stereotact Funct Neurosurg 1999;72(Suppl 1):119-24.
19. Landolt AM, Lomax N. Gamma knife radiosurgery for prolactinomas. J Neurosurg 2000;93(Suppl 3):13-8.
20. Morange-Ramos I, Regis J, Dufour H, Andrieu JM, Grisoli F, Jaquet P, et al. Short-term endocrinological results after gamma knife surgery of pituitary adenomas. Stereotact Funct Neurosurg 1998;70:127-38.
21. Pan L, Zhang N, Wang EM, Wang BJ, Dai JZ, Cai PW. Gamma knife radiosurgery as a primary treatment for prolactinomas. J Neurosurg 2000;93(Suppl 3):10-3.
22. Nishioka H, Ito H, Haraoka J, Hirano A. Growth potential of female prolactinomas. Surg Neurol 2001;55:213-7.